Table:
begin	end	state
1	22	signal peptide
23	34	non-cytoplasmic
35	54	transmembrane
55	83	cytoplasmic
84	105	transmembrane
106	121	non-cytoplasmic
122	141	transmembrane
142	147	cytoplasmic
148	173	transmembrane
174	192	non-cytoplasmic
193	212	transmembrane
213	229	cytoplasmic
230	252	transmembrane
253	277	non-cytoplasmic
278	307	transmembrane
308	327	cytoplasmic
328	347	transmembrane
348	353	non-cytoplasmic
354	376	transmembrane
377	393	cytoplasmic
394	411	transmembrane
412	415	non-cytoplasmic
416	434	transmembrane
435	445	cytoplasmic
446	470	transmembrane
471	473	non-cytoplasmic

Input:
>SMa1668
MAQKLSLFALTGMVVGSMVGAGIFSLPRTFGVATGPFGAIIAWCIAGGGMYMLARVFQSL
AERKPDLDAGVFAYAKEGFGDYPGFLSAFGYWIGSCIGNVSYWVLIKSTLGNFFPVFGDG
NTVVAILFASVGIWLFHFMILRGIQQAAFVNTVVTVAKVIPIIAFIIILFFFFKLDLFRL
NFWGGEGMPEATLLQQIQATMLATVFVFIGIEGASNYSRYAQARSDIGTATIMGFIGVSA
LMVLVTLLPYAALTRPEIAAMSQPSMAGVLAAVVGPWGAVFISIGVIVSVLGAYLAWSLV
CAEVLYVAARTDDMPRLFGTENQNKVPAAALWLTNIVVQLFVISTYWSQDAFALMLNLTS
SMSLIPYMFVAAFGFMLAQRAETYEVRPRERTRDLIIASIAAVYTFFMIVAGGIKFVLLS
ALLYAPGTILYFWARRERGKRVFNTSIDWLIFATAVIGCFAAIIGLSTGYLTI

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server